USE OF ASPIRIN IN THROMBOEMBOLIC DISEASE

[1] [Anonymous], 1972, Lancet, V2, P441

[2] CLAGETT G P, 1974, Surgical Forum (Chicago), V25, P473

[3] COMPARISON OF WARFARIN, LOW-MOLECULAR-WEIGHT DEXTRAN, ASPIRIN, AND SUBCUTANEOUS HEPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1974, A 56 (08) : 1552 - 1562

[4] ASPIRIN PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP-REPLACEMENT [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (23) : 1246 - 1249

[5] CLINICAL EVALUATION OF ASPIRIN PROPHYLAXIS OF THROMBOEMBOLIC DISEASE AFTER TOTAL HIP ARTHROPLASTY [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 926 - 928

[6] THROMBOEMBOLIC DISEASE IN PATIENTS UNDERGOING TOTAL KNEE REPLACEMENT [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 928 - 932

[7] OGRADY J, 1978, LANCET, V2, P780

[8] REDUCTION IN VENOUS THROMBOEMBOLISM BY AGENTS AFFECTING PLATELET FUNCTION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (23) : 1287 - +

[9] PREVENTION OF VENOUS THROMBOEMBOLISM IN ORTHOPEDIC PATIENTS [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 903 - 913

[10] ZEKERT F, 1973, 4 INT C THROMB HAEM, P281

[1] [Anonymous], 1972, Lancet, V2, P441

[2] CLAGETT G P, 1974, Surgical Forum (Chicago), V25, P473

[3] COMPARISON OF WARFARIN, LOW-MOLECULAR-WEIGHT DEXTRAN, ASPIRIN, AND SUBCUTANEOUS HEPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1974, A 56 (08) : 1552 - 1562

[4] ASPIRIN PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP-REPLACEMENT [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (23) : 1246 - 1249

[5] CLINICAL EVALUATION OF ASPIRIN PROPHYLAXIS OF THROMBOEMBOLIC DISEASE AFTER TOTAL HIP ARTHROPLASTY [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 926 - 928

[6] THROMBOEMBOLIC DISEASE IN PATIENTS UNDERGOING TOTAL KNEE REPLACEMENT [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 928 - 932

[7] OGRADY J, 1978, LANCET, V2, P780

[8] REDUCTION IN VENOUS THROMBOEMBOLISM BY AGENTS AFFECTING PLATELET FUNCTION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (23) : 1287 - +

[9] PREVENTION OF VENOUS THROMBOEMBOLISM IN ORTHOPEDIC PATIENTS [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1976, 58 (07) : 903 - 913

[10] ZEKERT F, 1973, 4 INT C THROMB HAEM, P281